Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2027
The global phosphatidylinositol 4,5 bisphosphate 3 kinase catalytic subunit beta isoform market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). This gene encodes an isoform of the catalytic subunit of phosphoinositide 3-kinase (PI3K) and is important in signalling pathways that involve receptors on the outer membrane of eukaryotic cells. The major factor driving the market growth include the rising prevalence of cancer across the globe.
According to the National Cancer
Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be
diagnosed in the US with a mortality rate of 606,520 people in 2020.
Additionally, the most common cancers are breast cancer, lung and bronchus
cancer, and leukemia, among others. In men, prostate, lung, and colorectal
cancers will account for an estimated 43% of all cancers diagnosed while for
women, the three most common cancers include breast, lung, and colorectal which
will account for an estimated 50% of all new cancer diagnoses in women in 2020
To Request a Sample of our Report on Phosphatidylinositol
4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market: https://www.omrglobal.com/request-sample/phosphatidylinositol-4-5-bisphosphate-3-kinase-catalytic-subunit-beta-isoform-market
Furthermore, there were 18.1 million new cases and 9.5
million cancer-related mortalities globally in 2018 which is anticipated to
rise to 29.5 million and the number of cancer-related mortalities to 16.4
million by 2040. Hence the rising prevalence of cancer is driving the demand
for phosphatidylinositol bisphosphate 3 kinase catalytic subunit beta isoform
due to its implicated in the treatment of cancer development and progression
which in turn is driving the growth of the market.
Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR)
signaling is one of the crucial intracellular pathways and therefore, it is regarded
as a master regulator for cancer. Some key players in the market include
AstraZeneca plc, Bayer AG, and GlaxoSmithKline Plc, among others.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Type
·
By Application
·
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- AstraZeneca Plc, Bayer AG, and
GlaxoSmithKline Plc, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Global Incubator Devices Market is Available @ https://www.omrglobal.com/request-sample/phosphatidylinositol-4-5-bisphosphate-3-kinase-catalytic-subunit-beta-isoform-market
Global Phosphatidylinositol Bisphosphate 3 Kinase Catalytic Subunit Beta
Isoform Market Report by Segment
By Type
·
PQR-514
·
KA-2237
·
GSK-2636771
·
BAY-1082439
·
Others
By Application
• Cancer
• Myelofibrosis
• Renal Cell Carcinoma
• Other
Global Phosphatidylinositol Bisphosphate 3 Kinase Catalytic Subunit Beta
Isoform Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries
are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment